Navigation Links
RPGSi Selects M2SYS Fingerprint Biometrics Software for Revolutionary Patient Identification System
Date:1/13/2009

Leading Healthcare Solutions Provider Integrates Award-Winning Fingerprint Recognition Solution

ATLANTA, Jan. 13 /PRNewswire/ -- M2SYS Technology, an award-winning fingerprint biometrics research and development firm, announced today that RPGSi Business Solutions, a provider of effective and high quality technology and information systems to Latin America, has integrated M2SYS' Bio-Plugin(TM) Appserver fingerprint software into its HealthGest(TM) healthcare software. RPGSi will be distributing the fingerprint recognition solution with M2SYS' M2-S(TM) optical fingerprint reader.

HealthGest(TM), a module of the TopSaude(TM) strategic e-health information system, supports the main activities of clinics in collaborative working environments and maintains the actions of public and private ambulatory health care units. With the integration of Bio-Plugin(TM) Appserver, an enterprise-ready, client/server fingerprint biometrics system that eliminates the development effort associated with a low-level fingerprint SDK, the identification of patients in the hospital will be more safe and efficient.

Luis Fernandes, Partner of RPGSi commented, "Most developing nations do not have a reliable method of identifying patients that are in need of healthcare services. Biometrics solves this problem and reduces the health risks to patients from misidentification. Furthermore, the M2SYS Bio-Plugin(TM) fingerprint software has helped us to address the challenge of creating a single Electronic Health Record to identify patients. By the end of this year, we expect to enroll and validate 30% of patients within our first community of 100,000 people," he stated.

"Proper identification of patients in developing countries is critical to provide quality healthcare. The addition of our Bio-Plugin(TM) software solution will give RPGSi a strong competitive advantage while providing their customers with the sophisticated identity protection that they require," stated Michael Trader, President of M2SYS Technology. "With this partnership, M2SYS has strengthened its position as a leading provider of fingerprint technology to the healthcare industry," he added.

About M2SYS

M2SYS Technology, www.m2sys.com, is a recognized industry leader in fingerprint identity management technology, delivering a wide range of customized, fully functional, turn-key fingerprint software solutions for businesses and consumers. M2SYS Technology was awarded the prestigious Frost and Sullivan Biometric Technology Innovation of the Year award in 2007.

About RPGSi

RPGSi, www.rpgsi.com, was founded in 2001 with a vision to provide its customers with efficient solutions with patterns of high quality, as well as areas of technologies and systems for information. RPGSi's main concern has always been its customers.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE M2SYS Technology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Womans Hospital Selects rL Solutions for Improved Adverse Event and Patient Safety Reporting
2. Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies
3. Business First Selects DRE Medical Equipment as a Company of the Year
4. BNC Technologies Selects Raima Database Manager Embedded
5. CMS Selects Palmetto GBA to Administer Medicare Program in Four States
6. Medical Economics Selects Jim Hohman to the 150 Best Financial Advisors for Doctors in America List
7. Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians
8. Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand
9. Excela Health Selects Allscripts Electronic Health Record for Physicians
10. Medical Specialists of the Palm Beaches Selects Allscripts Electronic Health Record to Connect and Automate 85 Physicians
11. Minnesota Power Selects InSteps eDNA Historian Software for Enterprise Operational and Asset Health Related Data Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: